Neogen Thyrocryn (levothyroxine sodium tablets) (2 products)
Recall announced April 12, 2023 by Neogen Corporation, posted by the U.S. Food and Drug Administration (FDA). Reason: Batch BN1209211 yielded subpotent Assay values as part of ongoing stability testing at the 15-month interval. Batches BN0711221 and BN0907221 are being removed from the market as part of the ongoing out of specification investigation. It affects dogs. The agency has not closed this recall.
- Brands
- Neogen
- Where sold
- CO, MO, NY, OH, FL, TX, IL, WA and Puerto Rico
- Last updated
- November 19, 2026
Products included
- Thyrocryn (levothyroxine sodium tablets), USP, 0.2 mg, Net Contents: [180 or 1000] tablets per bottle, For oral use in dogs only, Manufactured for:Aspen Veterinary Resources, LTD, Liberty, MO 64068. NDC 180 count bottle: 46066-091-38 (Lot, expiry: BN1209211, exp. 06-09-23; BN0711221, exp. 01-11-24; BN0907221, exp. 03-07-24)
- ThyroKare (levothyroxine sodium tablets), USP, 0.2 mg, Net Contents: [180 or 1000] tablets per bottle, For oral use in dogs only, Manufactured by:Neogen Corporation, 944 Nandino Blvd, Lexington, KY 40511. NDC 180 count bottle: 59051-9102-0 (Lot, expiry: BN1209211, exp. 06-09-23; BN0711221, exp. 01-11-24; BN0907221, exp. 03-07-24)
Read the official notice. Always compare the codes on your package with the official notice. It is the final word.
Has your pet used this product and seems unwell? Call your veterinarian or an emergency animal hospital now.
